Description

2-(6-Fluoro-2-Methyl-4-Oxoquinazolin-3(4H)-Yl)-n-(Pyridin-2-Ylmethyl)Acetamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel therapeutic agents. This compound is valued for its role as a key building block in medicinal chemistry, enabling the development of targeted drug candidates. It is primarily required by research institutions and pharmaceutical companies engaged in the discovery and development of new small-molecule drugs, particularly in oncology and other therapeutic areas.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel active pharmaceutical ingredients (APIs) and drug candidates.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for discovering new therapeutic molecules.
• Oncology Drug Development: Serves as a core scaffold for the research and development of targeted cancer therapies and kinase inhibitors.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for chemical biology studies and the exploration of new heterocyclic compounds.

Basic Information

Product Name	2-(6-Fluoro-2-Methyl-4-Oxoquinazolin-3(4H)-Yl)-n-(Pyridin-2-Ylmethyl)Acetamide
CAS No.	1574410-88-0
Molecular Formula	C₁₇H₁₅FN₄O₂
Molecular Weight	326.33 g/mol
Synonyms	2-[(6-Fluoro-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)]-N-(pyridin-2-ylmethyl)acetamide; 2-(6-Fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-(2-pyridylmethyl)acetamide; 3-[2-[(Pyridin-2-ylmethyl)amino]-2-oxoethyl]-6-fluoro-2-methyl-3,4-dihydroquinazolin-4-one; 1574410-88-0; 2-(6-Fluoro-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)-N-(pyridin-2-ylmethyl)acetamide
EINECS	Contact for details

Quality Control

Our 2-(6-Fluoro-2-Methyl-4-Oxoquinazolin-3(4H)-Yl)-n-(Pyridin-2-Ylmethyl)Acetamide is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.